Antimicrobial peptides including amyloid-beta itself may function as brain immune defenses against microbes, supporting the infectious hypothesis of Alzheimer's disease.
Aβ as antimicrobial peptideAmyloid-beta reframed from toxic waste to functional brain immune defense
What the researchers found
Antimicrobial peptides, including amyloid-beta, function as components of brain innate immunity against microbial invasion, supporting the infectious/antimicrobial hypothesis of Alzheimer's disease.
Why it matters
If Alzheimer's involves microbial triggers, the entire treatment paradigm shifts — from just clearing amyloid plaques to addressing underlying infections and modulating antimicrobial immune responses in the brain.
How the study worked
Narrative review synthesizing evidence from clinical studies and basic research on AMPs in Alzheimer's disease pathology.
What this study cannot tell us
Much evidence is correlational; causal relationships between infections and Alzheimer's remain debated; clinical trials targeting infections in AD have shown mixed results.
How to read the evidence
Narrative review of growing but still debated evidence — provides compelling hypothesis but not definitive proof of infectious causation.
When this study was published
Published in 2026, reflecting the latest developments in the antimicrobial hypothesis of Alzheimer's disease.
The bigger picture
Reframing amyloid-beta from a toxic waste product to a functional antimicrobial peptide fundamentally changes our understanding of Alzheimer's — suggesting plaques may be a protective immune response gone wrong rather than the primary cause of disease.
Questions still open
- Could antimicrobial or antiviral treatments slow Alzheimer's progression in patients with documented brain infections?
- Is chronic AMP activation in the brain protective or ultimately neurotoxic?
Common questions
Could infections cause Alzheimer's disease?
Does this mean amyloid plaques are actually protective?
Read the original research
Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer's disease.
Advances in protein chemistry and structural biology, 149, 395-418
Citation
Chandrashekar, Madhura; Velmurugan, Gowshika; Mishra, Amit; Chinnathambi, Subashchandrabose. (2026). Antimicrobial peptides act as a component of brain immunity against microbes in Alzheimer's disease.. Advances in protein chemistry and structural biology, 149, 395-418. https://doi.org/10.1016/bs.apcsb.2025.10.016